Table 3A.

Multinomial logistic regression analysis on chemotherapy type.

Characteristics	Recommended, but no chemo (n = 104, 6%)			Had chemo, single or multiple agent (n = 664, 35%)
	O.R.	95%	C.I.	O.R.	95%	C.I.
Race
White	1.00	–	–	1.00	–	–
African American	2.64	1.13	6.17	1.02	0.56	1.84
Hispanic	1.31	0.73	2.37	1.18	0.87	1.60
Asian/Pacific Islander	0.92	0.47	1.82	1.13	0.83	1.54
Insurance
Managed care	1.00	–	–	1.00	–	–
Medicare	0.76	0.40	1.46	0.58	0.41	0.83
Medicaid	0.84	0.38	1.88	0.90	0.61	1.33
Other ins	0.84	0.44	1.58	0.91	0.68	1.23
Not insured	0.98	0.33	2.91	1.08	0.64	1.82
SES
Lowest SES	1.23	0.49	3.08	0.91	0.61	1.36
Lower-middle SES	1.56	0.71	3.43	0.73	0.52	1.03
Middle SES	2.39	1.18	4.83	0.90	0.66	1.22
Higher-middle SES	2.74	1.37	5.48	1.02	0.76	1.38
Highest SES	1.00	–	–	1.00	–	–
Age	1.01	0.99	1.02	1.00	0.99	1.00
Grade
Grade I	1.00	–	–	1.00	–	–
Grade II	1.77	1.16	2.70	3.17	2.55	3.93
Histology
Serous	1.00	–	–	1.00	–	–
Mucinous	0.51	0.28	0.93	0.41	0.29	0.57
Endometrioid	0.56	0.32	0.98	0.80	0.59	1.08
Clear cell	1.10	0.29	4.16	2.51	1.29	4.89
Adenocarcinoma, NOS				0.33	0.13	0.88
Other	0.35	0.16	0.76	0.62	0.43	0.90
Tumor size
≤5 cm	1.00	–	–	1.00	–	–
5–10 cm	1.71	0.85	3.43	2.01	1.40	2.91
>10 cm	1.25	0.66	2.38	1.89	1.36	2.64
Unknown	1.06	0.54	2.05	1.37	0.98	1.93
Hospital volume
High volume	1.00	–	–	1.00	–	–
Low volume	0.88	0.50	1.55	0.56	0.43	0.73
Hospital type
ACoS approved	1.00	–	–	1.00	–	–
Not ACoS approved	0.92	0.53	1.60	0.70	0.54	0.91
Unknown	1.68	0.99	2.86	0.95	0.73	1.24
Physician volume
High volume	1.00	–	–	1.00	–	–
Low volume	1.36	0.69	2.67	0.77	0.58	1.01
Physician unknown	2.03	0.95	4.35	0.85	0.60	1.22

Outcome referent group is “No chemo — other reason”) on subset 1 of patients with stage IA or IIB and grade I or II tumor, (n = 1902).